Alpha-parvin/Actopaxin Antibody [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-00222FR
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunoprecipitation, Western Blot
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Produced in rabbits immunized with purified, recombinant Human Alpha-parvin/Actopaxin (Uniprot#: Q9NVD7-1; Met1-Glu372).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for Alpha-parvin/Actopaxin Antibody [DyLight 680]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: alpha-Parvin
Alternate Names
Actopaxin, alphaParvin, CH-ILKBP, MXRA2, PARVA
Gene Symbol
PARVA
Additional alpha-Parvin Products
Product Documents for Alpha-parvin/Actopaxin Antibody [DyLight 680]
Product Specific Notices for Alpha-parvin/Actopaxin Antibody [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...